The role of enamel matrix derivative protein in minimally invasive surgery in treating intrabony defects in single-rooted teeth: a randomized clinical trial

J Periodontol. 2011 Apr;82(4):522-32. doi: 10.1902/jop.2010.100454. Epub 2010 Nov 8.

Abstract

Background: This study investigates the impact of enamel matrix derivative (EMD) proteins on the outcome of a minimally invasive surgical technique (MIST) for the treatment of intrabony defects.

Methods: Thirty patients who presented with intrabony defects were randomly assigned to treatment with: 1) MIST plus EMD or 2) MIST alone. Probing depth (PD), position of the gingival margin (PGM), and relative clinical attachment level (RCAL) were evaluated at 3 and 6 months after treatment. Radiographs and markers in gingival crevicular fluid associated with periodontal regeneration were also evaluated.

Results: Significant PD reductions, RCAL gains, and no changes in PGM were obtained at 3 and 6 months in both groups. Clinical and radiographic evaluations and levels of mediators of wound healing did not present differences between therapies at any time.

Conclusion: The use of EMD did not provide superior benefits on the outcome of the minimally invasive surgical approach for the treatment of intrabony defects.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alveolar Bone Loss / diagnostic imaging
  • Alveolar Bone Loss / surgery*
  • Bone Regeneration / drug effects*
  • Bone Substitutes / therapeutic use*
  • Dental Enamel Proteins / therapeutic use*
  • Female
  • Gingival Crevicular Fluid / physiology
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Minimally Invasive Surgical Procedures / methods*
  • Periodontal Attachment Loss / diagnostic imaging
  • Periodontal Attachment Loss / therapy
  • Prospective Studies
  • Radiography
  • Single-Blind Method
  • Tooth Root
  • Treatment Outcome

Substances

  • Bone Substitutes
  • Dental Enamel Proteins
  • enamel matrix proteins